Literature DB >> 17513573

N-terminal prohormone brain natriuretic peptide: a biomarker for detecting cardiovascular risks in patients with rheumatoid arthritis or osteoarthritis?

Thomas Häupl, Gerd R Burmester, Evangelos Giannitsis, Thorsten Rohrlach, Eberhard Spanuth, Hans Parsch, Kay Brune.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17513573      PMCID： PMC1954649          DOI： 10.1136/ard.2006.066522

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis.

Authors:  S M J Harney; J Timperley; C Daly; A Harin; T James; M A Brown; A P Banning; K Fox; S Donnelly; B P Wordsworth
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

2.  High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis.

Authors:  Miguel A Gonzalez-Gay; Carlos Gonzalez-Juanatey; Angela Piñeiro; Carlos Garcia-Porrua; Ana Testa; Javier Llorca
Journal:  J Rheumatol       Date:  2005-07       Impact factor: 4.666

3.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

Authors:  I D del Rincón; K Williams; M P Stern; G L Freeman; A Escalante
Journal:  Arthritis Rheum       Date:  2001-12

4.  Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples.

Authors:  Thomas Mueller; Alfons Gegenhuber; Benjamin Dieplinger; Werner Poelz; Meinhard Haltmayer
Journal:  Clin Chem Lab Med       Date:  2004       Impact factor: 3.694

5.  The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.

Authors:  I Raymond; B A Groenning; P R Hildebrandt; J C Nilsson; M Baumann; J Trawinski; F Pedersen
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

6.  Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.

Authors:  Patrick H Dessein; Barry I Joffe; Sham Singh
Journal:  Arthritis Res Ther       Date:  2005-03-24       Impact factor: 5.156
  6 in total
  2 in total

1.  Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease.

Authors:  Cynthia S Crowson; Elena Myasoedova; John M Davis; Veronique L Roger; Barry L Karon; Daniel Borgeson; Richard J Rodeheffer; Terry M Therneau; Sherine E Gabriel
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-05       Impact factor: 4.794

2.  [Cardiovascular complications with cyclooxygenase inhibitors : Myths and facts].

Authors:  K Brune
Journal:  Z Rheumatol       Date:  2010-10       Impact factor: 1.372
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.